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1.1. Selective substrates of proteinase 3 produced through the use of
combinatorial chemistry
Human neutrophil elastase, cathepsin G and proteinase 3 are
synthesised and stored in the azurophilic granules of polymorpho-
nuclear neutrophils. These members of the serine protease family
are involved in several physiological processes such as degradation
of the components of the extracellular matrix (e.g. elastin, col-
lagen), and the control of cytokine activity (e.g. tumour necrosis
factor-a). Recent work has revealed that only proteinase 3 is in-
volved in the regulation of cell proliferation, and thus this 30-
kDa enzyme is an excellent target for drug discovery. However,
due to high sequence identity and nearly identical primary speciﬁ-
city with human neutrophil elastase, it is currently difﬁcult to dis-
criminate between the effects of these two proteinases. Published
efforts to date that attempt to provide some discrimination have
relied on the use of ﬂuorogenic substrates to investigate the prime
side of the enzyme catalytic site where the main structural differ-
ences between proteinase 3 and elastase are located.
Based on the crystal structures of both enzymes, it is clear that
the proteinase 3 substrate binding site is much more polar than in
the case of elastase. Speciﬁcally, proteinase 3 prefers a combina-
tion of charged and/or polar residues in the ﬁrst three prime posi-
tions, whereas elastase has a preference for small aliphatic non-
polar amino acid residues in the same region.
In order to advance knowledge of how one might better discri-
minate between these proteinases, recent work has disclosed ef-
forts on the synthesis and kinetic evaluation of a tripeptide
library with general formula ABZ-X3-X2-X1-ANB-NH2 that has been
designed to select ﬂuorogenic substrates of proteinase 3.1 In this
general formula, ABZ is an amino benzoic acid, ANB-NH2 is an
amide of 5-amino-2-nitrobenzoic acid, X2 and X3 are the set of
all proteinogenic amino acids except Cys, and X1 can be any of
the amino acids Ala, Abu, Val, Nva, Ser, Thr, Ile, Leu, and Nle.
In this study, theABZ andANB-NH2 groups at theN- andC-termini
of peptides synthesised servedasdonor and acceptor respectively, for
ﬂuorescence resonance energy transfer (FRET) within the peptides.
Sequences in the library that were selectively and efﬁciently hydro-
lysed by proteinase 3 were detected by a loss of their FRET signal.
To determine the inﬂuence ofmodiﬁcation, peptideswith 5-ami-
no-2-nitrobenzoic acid (ANB) and para-nitroanilide were synthe-E-mail: nterrett@ensemblediscovery.com
doi:10.1016/j.comche.2009.02.001sised and their activity as substrates for proteinase 3 and human
neutrophil elastase activitywere evaluated.After solid-phase synth-
esis of library members, followed by deconvolution, the isolated
peptides were assayed for the ability to resist enzymatic hydrolysis
by either proteinase 3 or human neutrophil elastase. Among pep-
tides present in the library, the most active ﬂuorogenic substrates
of proteinase 3 were selected and a determination of proteinase 3
substrate speciﬁcity and human neutrophil elastase substrate activ-
ity of selected librarymembers was carried out. One of the peptides
with the highest speciﬁcity constant for proteinase 3 ( kcat/ KM
=189103M-1 s-1)wasABZ-Tyr-Tyr-Abu-ANB-NH2. This compound
represents the ﬁrst example of a short peptide that undergoes selec-
tive proteolysis by proteinase 3 and displays no signiﬁcant hydroly-
sis in the presence of human neutrophil elastase. This approach
providesmethods for further investigation tobroaden theSAR in this
series, as well as progress towards more drug-like compounds.
1.2. Screening galectin ligands from combinatorial (glyco)peptide
libraries using surface plasmon resonance spectroscopy
The lectin family of galectins have been implicated in causing
undesired biological interactions. As they are involved in processes
such as angiogenesis, tumour spread and tumour invasion, the hu-
man galectins 1 and 3 are attractive targets for drug discovery. In
particular, interactions mediated by lectin–glycan recognition have
become a target for inhibitor development.
Recently, library screening approaches to detect sugar-based in-
hibitors have been undertaken. Galectins themselves are involved
in both carbohydrate–protein interactions as well as protein–pro-
tein interactions, and thus glycopeptide ligands may prove to be
versatile in the development of synthetic inhibitors. Glycopeptides
may be particularly useful in modulating galectin binding because
the carbohydrate moiety provides speciﬁcity, whereas the peptide
backbone may actively participate in binding by hydrogen bonding
or hydrophobic interactions. Glycopeptides can be generated in a
library format via a combinatorial approach. Several such libraries
have been generated via this strategy to date, and have allowed the
identiﬁcation of effective mimics. More recently, the systematic
examination of the capacity of human galectins 1- and 3-binding
glycopeptides to interfere with lectin–glycan interaction by surface
plasmon resonance has been reported.2
Several solid-phase libraries were synthesised on PEGA1900 re-
sin (0.2 mmol/g loading, 300–500 lM) and Wang resin (0.68
mmol/g loading, 200–400 mesh, pre-functionalised with a Rink
amide linker. Compounds were synthesised by the split-and-mix
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(approximately 25 mg, approximately 10,500 in number) were in-
cubated with the ﬂuorescently labelled galectin at a concentration
of 1.5 lM. The most ﬂuorescent beads were manually collected and
analysed by matrix-assisted laser desorption/ionisation time-of-
ﬂight mass spectrometry (MALDI–TOF MS). To systematically
deﬁne the inhibitory potency of a selection of resynthesised
glycopeptides, a surface plasmon resonance-based inhibition assay
with immobilised asialofetuin was used. For active mixtures,
re-synthesis and screening as singletons followed.
From this approach, a number of active compounds were ob-
tained. One of the most active glycopeptides was (iPIF(Lac-)TRR)
which possessed an IC50 of 25 lM for inhibition of galectin binding.
In this glycopeptide, P denotes the amino acid Pro, I is Ile, F is Phe, T
is Thr, R is Arg, and Lac is the sugar moiety Lac(b1-O)-coupled to
the threonine. Compounds synthesised via this library chemistry
have revealed the beneﬁcial effects of presenting the carbohydrate
ligand in a distinct hexapeptide context.
2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
An efﬁcient approach has been developed for the immobilisation
of a series of analogues of aloisine A, an in vitro inhibitor of protein
kinases, to polymeric supports via a [3 + 2] cycloaddition reaction.3
The efﬁciency of the pyruvoyl group as an amino protecting
group in solid phase peptide synthesis has been investigated. Both
Na-ﬂuorenylmethoxycarbonyl and (Fmoc)-Ne-pyruvoyl-lysine
were synthesised and introduced into peptides and glycopeptides
by the ordinary Fmoc-based solid phase peptide synthesis. The
pyruvoyl peptide could be condensed with a peptide thioester,
and was easily removed by o-phenylenediamine treatment with-
out signiﬁcant side reactions.4
Seven- and 10-membered cyclic thioenamino peptides have
been synthesised by both solid and solution-phase methods, and
the structure of one compound has been identiﬁed by X-ray dif-
fraction analysis of its TFA salt.5
Substitutedhydrazinesareprecursors formanycompoundsof con-
siderable scientiﬁc value. The synthesis of N’-substituted 2-(3,5-di-
methoxyphenyl)propan-2-yloxycarbonyl (Ddz) protected hydrazines
has been described, and using these materials, a general approach
for the solid phase synthesis of aza-peptides has been developed.6
2.2. Solution-phase synthesis
No papers this month.
2.3. Scaffolds and synthons for combinatorial libraries
A simple and convenient synthesis of orthogonally protected
multi-tethered, optically pure 2-ketopiperazine, diketopiperazine,
2-ketodiazepane and 3-aminopyrrolidone scaffolds for Fmoc com-
binatorial chemistry has been developed. The approach uses acces-
sible chiral amino acid precursors, sequentially applying reductive
alkylation, dipeptide coupling and regioselective ring formation as
key steps. These scaffolds provide expansion of the range of privi-
leged building blocks, and can introduce valuable drug-like proper-
ties in three independent directions to any medicinally relevant
piperazine-, diazepane- and pyrrolidone-based motif.7
2.4. Solid-phase supported reagents
In addition to their high afﬁnity for inorganic cations, crown
ethers have been shown to efﬁciently sequester ammonium ions,
forming a stable adduct via hydrogen bonding. The successful im-mobilisation of an 18-crown-6 ether derivative onto a solid
support has been reported and these have been incorporated into
a continuous ﬂow reactor whereby the sequestration of a series
of primary amine salts has been demonstrated.8
Copper (I), copper (II) and scandium (III) triﬂate complexes of
BOX and PYBOX ligands have been electrostatically immobilised
on silica. The performance of the immobilised catalysts in two car-
bonyl-ene reactions has been studied, and it compares very well
with that of their homogeneous equivalents.9
2.5. Novel resins, linkers and techniques
Combinatorial peptide libraries prepared by split-and-mix
synthesis on solid support can be decoded by amino acid analysis
(AAA) using the TAGSFREE method, which assigns variable amino
acids to ‘unique pair’ positions. The method has been used to inves-
tigate on-bead cyclisation in a library of 15,625 octapeptides
X8X7X6X5X4-Lys-X2-glu(b-Ala-b-Ala-TentaGel Macrobead)-OAllyl,
anchored via the side-chain carboxylate of the d-glutamate. Cycli-
sation was carried out by amide bond formation between the free
N-terminus and the a-carboxyl group of d-glutamate after selec-
tive removal of the Fmoc and allyl protecting groups. It was found
that fast-cyclising sequences often contained a turn element, and
gave higher preparative yields of cyclic peptides.10
2.6. Library applications
High-throughput screening of a library of diverse molecules has
identiﬁed the 1,4-naphthoquinone scaffold as a new class of Hsp90
inhibitors. The synthesis and evaluation of a rationally-designed li-
brary of analogues containing the naphthoquinone core scaffold
has provided key structure-activity relationships for these com-
pounds. Themost active inhibitors exhibited potent in vitro activity
with low micromolar IC50 values in anti-proliferation and Her2 de-
gradation assays, and some compounds induced the degradation of
oncogenic Hsp90 client proteins, a hallmark of Hsp90 inhibition.11
Matrix metalloproteinase-14 (MT1-MMP or MMP-14) is a
membrane-associated protease implicated in a variety of tissue re-
modelling processes and a molecular marker of some metastatic
cancers. A combination of computational chemistry, parallel synth-
esis and biochemical screening has been used to develop new tech-
netium-99m radiolabelled probes that are sensitive to protease
activity. These have potential in studying the role of MMP-14 in
pathologic processes and may serve as guides for the development
of targeted molecular therapies.12
A novel 1,4-benzoxazin-3-one derivative with inhibitory activ-
ities against tyrosine kinases has been designed and synthesised.
The method has been used for the preparation of a novel 1,4-ben-
zoxazin-3-one chemical library which has been used to determine
inhibitory activities against the kinases, KDR and ABL.13
The prolactin receptor is involved in normal lactation and re-
production. However, excessive prolactin levels can cause various
reproductive disorders such as prolactinomas. Small-molecule an-
tagonists against the human prolactin receptor (hPRLr) have po-
tential clinical applications and may serve as useful molecular
probes in biomedical research. A large, support-bound cyclic pep-
tide library (theoretical diversity of 1.2  107) has been prepared
on 90-lm TentaGel beads and screened against the extracellular
domain of hPRLr, resulting in 20 hits. Two of these were selected
for further analysis and were shown to bind to hPRLr with dissocia-
tion constants of 2–3 lM.14
Resveratrol (4,30,50-trihydroxystilbene) is a naturally occurring
antioxidant that inhibits cyclooxygenase-1 (COX-1), cyclooxygen-
ase-2 (COX-2) and the transcription factor NF-jB. A 78-membered
library of resveratrol analogues in which the substituents on the
two aryl rings and alkene were varied has been synthesised using
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inhibitors against all three proteins that were more potent than re-
sveratrol itself, and preliminary structure–activity relationships
were also obtained from these data that permitted the derivation
of pharmacophore models for each of the three targets.15
The Ellman group has been one of the most inﬂuential in the de-
velopment and widespread adoption of combinatorial chemistry
techniques for biomedical research. Their work has included sub-
stantial methodological development for library synthesis with a
particular focus on new scaffolds rationally targeted to biomole-
cules of interest and biologically relevant natural products. This re-
view analyses a representative set of libraries from this group with
respect to their biological and biomedical relevance in comparison
to existing drugs and probe compounds.16
Proteases are a family of naturally occurring enzymes in the
body whose dysregulation has been implicated in numerous dis-
eases and cancers. This review focuses on the development of ac-
tivity-based methodologies to characterise proteases, and in
particular, the use of positional scanning, synthetic combinatorial
libraries (PS-SCL’s), and substrate activity screening (SAS) assays.17
Maslinic acid has been coupled at C-28 with several a- and x-
amino acids by using solution- and solid-phase synthetic proce-
dures. Twelve derivatives with a single amino acid residue were
prepared in solution phase, whereas a dipeptide, a tripeptide, and
a series of conjugate dipeptides have been synthesised on solid
support. The anti-HIV activity of these compounds has been as-
sessed on MT-2 cells infected with viral clones carrying the lucifer-
ase gene as a reporter.18
The solid-phase parallel synthesis and SAR of 4-amidofuran-3-
one inhibitors of cathepsin S have been described. Highly potent
inhibitors have been described, and the synthesis and structure–
activity relationship of the compounds with a sulphonamide moi-
ety in the P3 position have been presented. Several members of the
series show sub-nanomolar inhibition of the target enzyme, and
molecular modelling described interactions in the extended S3
pocket and the observed selectivity towards cathepsin K.19
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